BIOMAT Database Logo BIOMAT Database Logo

Copper-histidine treatment of Menkes disease. 1994

A Garnica, and W Y Chan, and O Rennert

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007706 Menkes Kinky Hair Syndrome An inherited disorder of copper metabolism transmitted as an X-linked trait and characterized by the infantile onset of HYPOTHERMIA, feeding difficulties, hypotonia, SEIZURES, bony deformities, pili torti (twisted hair), and severely impaired intellectual development. Defective copper transport across plasma and endoplasmic reticulum membranes results in copper being unavailable for the synthesis of several copper containing enzymes, including PROTEIN-LYSINE 6-OXIDASE; CERULOPLASMIN; and SUPEROXIDE DISMUTASE. Pathologic changes include defects in arterial elastin, neuronal loss, and gliosis. (From Menkes, Textbook of Child Neurology, 5th ed, p125) Hypocupremia, Congenital,Kinky Hair Syndrome,Menkes Syndrome,Steely Hair Syndrome,Congenital Hypocupremia,Copper Transport Disease,Kinky Hair Disease,Menkea Syndrome,Menkes Disease,Menkes' Disease,Steely Hair Disease,X-Linked Copper Deficiency,Congenital Hypocupremias,Copper Deficiencies, X-Linked,Copper Deficiency, X-Linked,Copper Transport Diseases,Deficiencies, X-Linked Copper,Deficiency, X-Linked Copper,Disease, Copper Transport,Disease, Steely Hair,Diseases, Copper Transport,Diseases, Kinky Hair,Diseases, Menkes',Diseases, Steely Hair,Hair Diseases, Kinky,Hair Diseases, Steely,Hypocupremias, Congenital,Kinky Hair Diseases,Menkea Syndromes,Menkes' Diseases,Steely Hair Diseases,Steely Hair Syndromes,Syndrome, Menkea,Syndrome, Steely Hair,Syndromes, Menkea,Syndromes, Steely Hair,Transport Disease, Copper,Transport Diseases, Copper,X Linked Copper Deficiency,X-Linked Copper Deficiencies
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D003300 Copper A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55. Copper-63,Copper 63
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006639 Histidine An essential amino acid that is required for the production of HISTAMINE. Histidine, L-isomer,L-Histidine,Histidine, L isomer,L-isomer Histidine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Garnica, and W Y Chan, and O Rennert
[Intramuscular copper histidine treatment in Menkes disease].
May 1992, No to hattatsu = Brain and development,
A Garnica, and W Y Chan, and O Rennert
Early copper-histidine treatment for Menkes disease.
January 1996, Nature genetics,
A Garnica, and W Y Chan, and O Rennert
Treatment of Menkes disease with parenteral copper histidine.
February 2002, Indian pediatrics,
A Garnica, and W Y Chan, and O Rennert
Copper-histidine therapy for Menkes disease.
November 1993, The Journal of pediatrics,
A Garnica, and W Y Chan, and O Rennert
Menkes disease mutations and response to early copper histidine treatment.
May 1996, Nature genetics,
A Garnica, and W Y Chan, and O Rennert
Early copper histidine therapy in classic Menkes disease.
January 1997, Annals of neurology,
A Garnica, and W Y Chan, and O Rennert
Menkes disease after copper histidine replacement therapy: case report.
January 2001, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society,
A Garnica, and W Y Chan, and O Rennert
Clinical and biochemical consequences of copper-histidine therapy in Menkes disease.
October 1993, European journal of pediatrics,
A Garnica, and W Y Chan, and O Rennert
Menkes disease and response to copper histidine: An Indian case series.
January 2017, Annals of Indian Academy of Neurology,
A Garnica, and W Y Chan, and O Rennert
Novel mutations and clinical outcomes of copper-histidine therapy in Menkes disease patients.
February 2015, Metabolic brain disease,
Copied contents to your clipboard!